Allied Biotech Corporation
1780.TWO
Price:
$24.5
Market Cap:
$2.36B
Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharmaceutical products. The company also provides Canthaxanthin, which offers a range of shades of reddish orange for food and beverage applications; Lutein, a carotenoid that provides a range of green leafed vegetables, such as spinach, kale, broccoli, and egg yolks.; and Nano Coenzyme Q10, an antioxida...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
1780.TWO
PE Ratio
[25.00]
ROE
[-4.90%]
Current Ratio
[1.51]
Dividend Yield
[4.08%]
Enterprise Value
[2.28B]
Dividend History
The Enterprise Value as of December 2025 (TTM) for Allied Biotech Corporation (1780.TWO) is 2.28B
According to Allied Biotech Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 2.28B. This represents a change of 32.08% compared to the average of 1.73B of the last 4 quarters.
Allied Biotech Corporation (1780.TWO) Historical Enterprise Value (quarterly & annually)
How has 1780.TWO Enterprise Value performed in the past?
The mean historical Enterprise Value of Allied Biotech Corporation over the last ten years is 1.07B. The current 2.28B Enterprise Value has changed 21.28% with respect to the historical average. Over the past ten years (40 quarters), 1780.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 1.89B. The Enterprise Value was at its lowest in in the June 2013 quarter at 0.
Average
1.07B
Median
1.57B
Minimum
0
Maximum
1.94B
Allied Biotech Corporation (1780.TWO) Enterprise Value by Quarter and Year
Discovering the peaks and valleys of Allied Biotech Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 1.94B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 1.65B | -4.79% |
| 2023 | 1.73B | 15.71% |
| 2022 | 1.50B | -22.92% |
| 2021 | 1.94B | 2.66% |
| 2020 | 1.89B | -2.61% |
| 2019 | 1.94B | Infinity% |
| 2018 | 0 | 0% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
| 2015 | 0 | 0% |
Allied Biotech Corporation (1780.TWO) Average Enterprise Value
How has 1780.TWO Enterprise Value performed in the past?
The current Enterprise Value of Allied Biotech Corporation (1780.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.63B
5-year avg
1.74B
10-year avg
1.07B
Allied Biotech Corporation (1780.TWO) Enterprise Value vs. Peers
How is 1780.TWO’s Enterprise Value compared to its peers?
Allied Biotech Corporation’s Enterprise Value is greater than LIWANLI Innovation Co., Ltd. (1.71B), greater than TSH Biopharm Corporation Limited (1.62B), greater than Winston Medical Supply Co., Ltd. (1.40B), greater than InnoPharmax Inc. (2.10B), greater than Arich Enterprise Co., Ltd. (979.25M), greater than Chi Sheng Pharma & Biotech Co., Ltd (1.58B), greater than Tien Liang BioTech Co., Ltd. (1.76B), greater than Shangya Technology Co., Ltd. (2.02B), greater than Perfect Medical Industry Co., Ltd. (1.71B), greater than Excelsior Biopharma Inc. (1.62B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.71B | $1.91B | |
| 1.62B | $2.13B | |
| 1.40B | $1.71B | |
| 2.10B | $2.28B | |
| 979.25M | $1.58B | |
| 1.58B | $1.78B | |
| 1.76B | $1.39B | |
| 2.02B | $2.06B | |
| 1.71B | $1.68B | |
| 1.62B | $1.36B |
Build a custom stock screener for Allied Biotech Corporation (1780.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Allied Biotech Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Allied Biotech Corporation (1780.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Allied Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Allied Biotech Corporation's Enterprise Value?
What is the highest Enterprise Value for Allied Biotech Corporation (1780.TWO)?
What is the 3-year average Enterprise Value for Allied Biotech Corporation (1780.TWO)?
What is the 5-year average Enterprise Value for Allied Biotech Corporation (1780.TWO)?
How does the current Enterprise Value for Allied Biotech Corporation (1780.TWO) compare to its historical average?